What is it about?
Neonatal meningitis can result in adverse outcomes including increase mortality and morbidity. This is a review of the pharmacological management for a neonatal patient presenting with a differential diagnosis of meningitis either early and late onset and when diagnosis is confirmed or suspected.
Featured Image
Photo by Alexander Grey on Unsplash
Why is it important?
The review is part of a continued professional development series for independent non-medical prescribers and includes pharmacological and reflective questions. Completing the activities will support evidencing competency and professional revalidation.
Perspectives
This series of CPD brief reviews of topics of interest to non-medical prescribers supports my professional development as an educator and independent nurse prescriber.
Dr Sonya MacVicar
Edinburgh Napier University
Read the Original
This page is a summary of: Antimicrobial treatment of neonatal meningitis, Journal of Prescribing Practice, January 2024, Mark Allen Group,
DOI: 10.12968/jprp.2024.6.1.16.
You can read the full text:
Contributors
The following have contributed to this page
